We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$8.13M
Cap. Flow
-$386K
Cap. Flow %
-0.19%
Top 10 Hldgs %
70.75%
Holding
559
New
10
Increased
273
Reduced
67
Closed
18

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.16M
2
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$1.07M
3
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$1.02M
4
FM
iShares Frontier and Select EM ETF
FM
+$976K
5
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$907K

Top Sells

Rank Stock Value
1
IWX icon
iShares Russell Top 200 Value ETF
IWX
+$6.51M
2
IWY icon
iShares Russell Top 200 Growth ETF
IWY
+$6.5M
3
BAC icon
Bank of America
BAC
+$1.1M
4
IEI icon
iShares 3-7 Year Treasury Bond ETF
IEI
+$346K
5
INFO
IHS Markit Ltd. Common Shares
INFO
+$198K

Sector Composition

Rank Sector Weight
1 Financials 3.18%
2 Healthcare 2.1%
3 Technology 2.05%
4 Industrials 1.87%
5 Communication Services 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HXL icon
151
Hexcel
HXL
$7.73B
$80K 0.04%
1,474
+418
+40% +$22K
SPB icon
152
Spectrum Brands
SPB
$2.04B
$80K 0.04%
581
+19
+3% +$2.52K
ABEV icon
153
Ambev
ABEV
$47.1B
$79K 0.04%
13,815
+5,982
+76% +$32.8K
MLM icon
154
Martin Marietta Materials
MLM
$32.6B
$78K 0.04%
358
– –
AGN
155
DELISTED
Allergan plc
AGN
$76K 0.04%
321
+92
+40% +$21.4K
AMJ
156
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$75K 0.04%
2,329
+3
+0.1% +$98
GSK icon
157
GSK
GSK
$103B
$74K 0.04%
1,414
+3
+0.2% +$152
HCA icon
158
HCA Healthcare
HCA
$88B
$73K 0.04%
828
+424
+105% +$35.4K
XLK icon
159
State Street Technology Select Sector SPDR ETF
XLK
$117B
$73K 0.04%
2,750
– –
ORAN
160
DELISTED
Orange
ORAN
$72K 0.03%
4,656
+1,711
+58% +$26.6K
GILD icon
161
Gilead Sciences
GILD
$163B
$70K 0.03%
1,034
+323
+45% +$22.7K
KT icon
162
KT
KT
$8.75B
$70K 0.03%
4,215
+1,801
+75% +$27.9K
ROST icon
163
Ross Stores
ROST
$81.1B
$70K 0.03%
1,074
+314
+41% +$21K
TMO icon
164
Thermo Fisher Scientific
TMO
$212B
$70K 0.03%
+457
New +$69.8K
USG
165
DELISTED
Usg
USG
$70K 0.03%
2,228
– –
EMR icon
166
Emerson Electric
EMR
$86.7B
$69K 0.03%
1,166
+6
+0.5% +$358
HSBC icon
167
HSBC
HSBC
$370B
$69K 0.03%
1,871
+440
+31% +$16.5K
SHM icon
168
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
$68K 0.03%
1,414
-81
-5% -$3.91K
WRK
169
DELISTED
WestRock Company
WRK
$68K 0.03%
1,319
+9
+0.7% +$475
ELV icon
170
Elevance Health
ELV
$83B
$66K 0.03%
403
+180
+81% +$28.6K
UMC icon
171
United Microelectronic
UMC
$46.9B
$66K 0.03%
34,261
+15,074
+79% +$28.6K
XRX icon
172
Xerox
XRX
$411M
$66K 0.03%
2,273
+630
+38% +$18.2K
NVS icon
173
Novartis
NVS
$292B
$65K 0.03%
989
+242
+32% +$16.1K
OA
174
DELISTED
Orbital ATK, Inc.
OA
$65K 0.03%
670
-27
-4% -$2.5K
CELG
175
DELISTED
Celgene Corp
CELG
$65K 0.03%
526
+287
+120% +$34.3K
5 6
7
8 9

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
WWA
WCG Wealth Advisors Las Vegas, Nevada $3.57B AUM 18.63% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BPS
BNDES Participacoes SA Rio De Janeiro, Brazil $3.58B AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Arax Advisory Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Arax Advisory Partners held 559 positions worth $208M, up 4.1% from $200M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Arax Advisory Partners's Q1 2017 filing shows 10 new, 273 increased, 67 reduced and 18 closed positions. Its largest new stake was Thermo Fisher Scientific: 457 shares worth $70K. The largest sale was iShares Russell Top 200 Value ETF, an estimated $6.51M.

By sector, the portfolio is most concentrated in Financials at 3.2% of assets, down from 3.6% a quarter earlier, followed by Healthcare and Technology.

  • Arax Advisory Partners's largest Q1 2017 buy was Thermo Fisher Scientific: 457 shares worth $70K.
  • Arax Advisory Partners added most to Vanguard FTSE Developed Markets ETF in Q1 2017, an estimated $1.16M increase.
  • Arax Advisory Partners's biggest Q1 2017 reduction was iShares Russell Top 200 Value ETF, cutting an estimated $6.51M.
  • Arax Advisory Partners fully exited SRC Energy Inc in Q1 2017, selling an estimated $195K.
  • Arax Advisory Partners's ten largest holdings make up 71% of its $208M portfolio in Q1 2017.
  • Arax Advisory Partners opened 10 new positions and closed 18 in Q1 2017.
  • Arax Advisory Partners's portfolio value rose 4.1% quarter-over-quarter to $208M.

Based on Arax Advisory Partners's 13F filing for Q1 2017, filed 12 May 2017.